If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksVolex Regulatory News (VLX)

Share Price Information for Volex (VLX)

Share Price is delayed by 15 minutes
Get Live Data
497.00    -8.00 (-1.58%)
Bid:
494.00
Ask:
496.00
Spread: 2.00 (0.405%)
Market Cap: £915.84m
VLX Live PriceLast checked at - London Stock Exchange

Intraday Volex Share Chart

Holding(s) in Company

25 Jan 2010 15:00

RNS Number : 0823G
Volex Group PLC
25 January 2010
Β 

ο»Ώ

TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES

1. Identity of the issuer or the underlying issuerΒ of existing shares to which voting rights areΒ attached:

Volex Group Plc

2 Reason for the notificationΒ (please tick the appropriate box or boxes):

An acquisition or disposal of voting rights

YesΒ 

An acquisition or disposal ofΒ qualifyingΒ financial instruments which may result in theΒ acquisition of shares already issuedΒ to which voting rights are attached

No

An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments

No

An event changing the breakdown of voting rights

No

Other (please specify):

No

3. Full name of person(s) subject to theΒ notification obligation:

Gartmore Investment Limited

4. Full name of shareholder(s)Β (if differentΒ from 3.):

Gartmore Investment Limited

Β 

Gartmore Fund Managers Limited

5. Date of the transaction and date onΒ which the threshold is crossed orΒ reached:

21stΒ January 2010

6.Β Date on which issuer notified:

22ndΒ January 2010

7. Threshold(s) that is/are crossed orΒ reached:

11%

Β Β 

8. Notified details:

A: Voting rights attached to shares

Class/type of shares

if possible using the ISIN CODE

Situation previous to theΒ triggering transaction

Resulting situation after the triggering transaction

Number of Shares

Number of Voting Rights

Number of shares

Number of voting rights

% of voting rights

Direct

Direct

Indirect

Direct

Indirect

G80009390070

7,021,620

7,021,620

6,821,620

6,821,620

11.988%

Β 

B:Β QualifyingΒ Financial Instruments

Resulting situation after the triggering transaction

Type of financial instrument

Expiration date

Exercise/Β ConversionΒ Period

Number of voting rights that may be acquired if the instrument is exercised/ converted.

% of voting rights

Β 

Β 

Β 

Β 

Β 

C:Β FinancialΒ Instruments with similar economic effect to QualifyingΒ FinancialΒ Instruments

Resulting situation after the triggering transaction

Type of financial instrument

ExerciseΒ price

ExpirationΒ date

Exercise/ ConversionΒ period

Number of votingΒ rights instrumentΒ refers to

% of voting rights

Β 

Β 

Β 

Β 

Β 

Nominal

Delta

Β 

Β 

Total (A+B+C)

Number of voting rights

PercentageΒ of voting rights

6,821,620

11.988%

9. Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held, if applicable:

Β 

Proxy Voting:

10. Name of the proxy holder:

Β 

11. Number of voting rights proxy holder will ceaseΒ to hold:

Β 

12. Date on which proxy holder will cease to holdΒ voting rights:

Β 

13. Additional information:

All figuresΒ areΒ based onΒ the company's issuedΒ shareΒ capital of 56,901,563 as providedΒ byΒ Exshare

E mailΒ contactΒ RDU@Gartmore.com

14. Contact name:

RDU

15. Contact telephone number:

0207Β 782 2324

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
HOLBSGDBCUDBGGU
Date   Source Headline
25th Jun 20267:00 amRNSPreliminary Group Results FY2026
25th Jun 20267:00 amRNSUpdate on Move to the Main Market
26th May 20263:00 pmRNSNotice of Results
15th May 20267:45 amRNSHolding(s) in Company
11th May 20267:00 amRNSHolding(s) in Company
30th Apr 20263:07 pmRNSHolding(s) in Company
22nd Apr 20267:00 amRNSCapital Markets Event
7th Apr 20267:00 amRNSLaunch of £40 million Share Buyback Programme
7th Apr 20267:00 amRNSUpdate on Move to the Main Market
26th Mar 20265:30 pmRNSHolding(s) in Company
25th Mar 20267:00 amRNSTrading update and Notice of Capital Markets Event
20th Mar 20262:00 pmRNSDirector/PDMR Shareholding
10th Feb 20267:45 amRNSHolding(s) in Company
2nd Feb 20264:45 pmRNSDirector/PDMR Shareholding
30th Jan 20264:30 pmRNSDirector/PDMR Shareholding
21st Jan 20267:00 amRNSTrading Update
12th Jan 20265:30 pmRNSDirector/PDMR Shareholding
8th Jan 20262:00 pmRNSDirector/PDMR Shareholding
5th Jan 20263:00 pmRNSIssue of Equity and Total Voting Rights
15th Dec 20257:00 amRNSDirector/PDMR Shareholding
11th Dec 20255:55 pmRNSDirector/PDMR Shareholding
4th Dec 202511:30 amRNSScrip Reference Price
12th Nov 20257:00 amRNSAppointment of Non-Executive Chair and CEO
12th Nov 20257:00 amRNSHalf-year Report
20th Oct 20257:00 amRNSNotice of Results
16th Oct 20257:00 amRNSHalf Year Trading Update
29th Sep 20251:25 pmRNSHolding(s) in Company
18th Sep 20257:00 amRNSHolding(s) in Company
15th Sep 202511:30 amRNSDirector/PDMR Shareholding
15th Sep 202510:15 amRNSHolding(s) in Company
5th Sep 20259:00 amRNSDirector/PDMR Shareholding
1st Sep 20251:00 pmRNSIssue of Equity and Total Voting Rights
7th Aug 20254:35 pmRNSResult of AGM
7th Aug 202512:30 pmRNSScrip Reference Price
7th Aug 20257:00 amRNSAGM Statement
4th Aug 20252:00 pmRNSHolding(s) in Company
7th Jul 20254:35 pmRNSPDMR / PCA Shareholding
4th Jul 202511:00 amRNSNotice of AGM and Publication of Annual Report
26th Jun 20257:00 amRNSPreliminary Group Results FY2025
2nd Jun 20257:00 amRNSNotice of Results and Investor Presentation
16th Apr 20252:00 pmRNSDirector/PDMR Shareholding
16th Apr 20251:00 pmRNSDirector/PDMR Shareholding
10th Apr 20256:00 pmRNSDirector/PDMR Shareholding
7th Apr 20257:00 amRNSFull Year Trading Update
19th Mar 20253:30 pmRNSDirector/PDMR Shareholding
13th Mar 20255:45 pmRNSHolding(s) in Company
27th Jan 20257:00 amRNSChange of Adviser
27th Jan 20257:00 amRNSTrading Update
16th Jan 20251:15 pmRNSDirector/PDMR Shareholding
16th Jan 20251:15 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.